$ONTO

Cantor Fitzgerald reiterates Onto Innovation stock rating at Overweight

Cantor Fitzgerald reiterated an Overweight rating and $410 price target for Onto Innovation (NYSE:ONTO) after meeting with executives. The firm noted recent negative sentiment but believes it's overdone, citing positive growth dynamics. ONTO stock is down 14% this week but up 67% year-over-year. The company will host an analyst day on December 17. Recent Q2 earnings beat expectations, with revenue of $343.1M and EPS of $1.93. Multiple analysts have set price targets ranging from $330 to $450.

Original reporting
Published Oct 20, 2026, 12:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 12:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ONTO
Bullish
medium confidence
Mentioned
$ONTO
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ONTOBullishLow
01

Why it matters

While the rating and price target are new, the underlying earnings numbers have already been disclosed, reducing the overall trading relevance.

02

Market read

Modest impact limited to investors following analyst recommendations for ONTO.

03

What to watch

Potential slowdown in AI‑driven demand or supply‑chain constraints may limit upside.

Relevance 4/10Novelty 2/10Timing: today

Background

The article recaps recent analyst coverage and Q2 2026 results for Onto Innovation, emphasizing Cantor Fitzgerald's reiteration of an Overweight rating.

Company-level read

Ticker impact

$ONTOBullishMedium confidence
Context

Cantor Fitzgerald reiterated an Overweight rating and $410 price target for Onto Innovation, noting recent negative sentiment but calling it overdone.

Expected impact

likely upward pressure as investors consider the new $410 target and overweight stance

Evidence & confidence

The rating upgrade and high price target provide a fresh catalyst, but the underlying earnings data have been previously reported, limiting novelty.

Market effects

Analyst optimism may lift sentiment in the semiconductor equipment sector.

US semiconductor stocks could see modest gains.

Limited to investors tracking wafer‑fab equipment makers.

Counterpoint

The negative sentiment around TSMC orders and margin pressure could outweigh the rating upgrade.

Key entities

  • Onto Innovation Inc.

    US‑listed semiconductor equipment maker (ticker ONTO).

  • Cantor Fitzgerald

    Equity research firm providing the rating and price target.

Related articles

$ONTOHigh

Why is Onto Innovation stock surging today?

Onto Innovation (ON) stock rose 5.6% to $332.47 after RBC initiated coverage with an Outperform rating and $400 target, citing growth in chipmaking segments and the Dragonfly G5 platform. The company reported Q2 2026 revenue of $343M, up 35% YoY, and a backlog exceeding $1B. The surge also followed a positive U.S. equities session and weaker jobs data, reducing Fed rate hike expectations.

$ONTOHigh

Onto Innovation gains on bullish RBC initiation citing advanced packaging growth

Onto Innovation (NYSE:ONTO) shares rose 5.4% after RBC Capital initiated coverage with an Outperform rating and $400 price target. The firm cited the company's exposure to advanced packaging technologies and strong long-term capital equipment positioning. RBC expects Onto to outpace broader wafer fabrication equipment spending due to increased investments in 2.5D and 3D chip architectures.

$ONTOHighAI 9/10

Onto Innovation (ONTO) Bets $720M on X-Ray Chip Technology

Onto Innovation (ONTO) acquired a 27% stake in Rigaku Holdings for $720M, expanding its X-ray chip tech collaboration. Q2 2026 revenue rose 35.3% YoY to $343.1M, beating guidance. Backlog exceeded $1B. Q3 guidance: $380M-$400M revenue, EPS $2.18-$2.38. H1 2026 net income fell to $93.9M from $98M YoY, with margins declining.

$LUNRMed

Stocks making the biggest moves midday: EyePoint, Intuitive Machines, Workday, JetBlue & more

Midday movers included Intuitive Machines, up about 9% after saying it received an authorization to proceed for a $600 million multisatellite communications program. EyePoint Pharmaceuticals fell about 70% after its Phase 3 wet AMD treatment failed its primary goal. JetBlue dropped 6% after a Seaport Research downgrade. Onto Innovation rose on Goldman coverage. Workday fell after a Deutsche Bank downgrade. Memory chip stocks rose after comments on Apple buying Chinese chips.